My parents both suffered from ME / CFS and I was diagnosed with ME / CFS and FIBROMYALGIA in April of 2012. I was bedridden for about a year
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) is a poorly understood disease of unknown etiology that affects 0.1%–0.2% of the population, according to Canadian consensus criteria. Compared
OMF is pleased to acknowledge and honor journalist and scholar, David Tuller, DrPH. David is the academic coordinator of University of California Berkeley’s joint master’s
Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study (and all the sub-studies within it) and the
OMF’s End ME / CFS Project is the most comprehensive, revolutionary research to find a biomarker, treatment and cure for ME / CFS and related chronic, complex diseases. “I
Author and patient Naomi Whittingham shares her story on openDemocracy to raise awareness of ME / CFS: I live in a world largely hidden from view. Most of
OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo
Copyright © 2025 Open Medicine Foundation. All Rights Reserved.
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
